MIR3611

Across TCGA pan-cancer cohorts, MIR3611 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR3611 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR3611 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3611 expression acts as an unfavorable survival marker, although some lineages such as STAD and LUAD show a favorable association.

UCEC, DLBC, and SKCM are the cancer types where MIR3611 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.621	0.846	<.001	108	view →
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	63	view →
SKCM	DFS	Tertile	III,IV	0.061	0.664	<.001	18	view →
GBM	OS	Tertile	All	0.005	0.416	<.001	18	view →
STAD	OS	Quartile	All	0.587	0.372	.013	11	view →
LUAD	DFS	Tertile	All	0.599	0.334	.030	9	view →
SARC	OS	Tertile	All	0.127	0.860	<.001	9	view →
LAML	DFS	Tertile	All	0.518	0.259	.047	8	view →
ESCA	OS	Quartile	III,IV	0.637	0.324	.036	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR3611–UCEC (DFS)

Open the UCEC breakdown →